March 29, 2023
Lucy Therapeutics, Inc. announced the appointment of Christopher J. Winrow, Ph.D., a neuroscience and translational medicine expert, as Chief Scientific Officer.
Visit LinkOctober 13, 2022
Lucy Therapeutics Debuts Novel Therapeutic Agents for Parkinson’s Disease at Michael J. Fox Foundation Annual Conference
Visit LinkApril 11, 2022
Lucy Therapeutics Receives $4.9 Million Grant from Michael J. Fox Foundation
Visit LinkMarch 8, 2023
PharmaVoice
How a 3.2-million-year-old fossil inspired the CEO to unlock the mysteries of mitochondrial dysfunction.
Visit LinkJanuary 3, 2023
Cultivating Greatness
Amy Ripka, Founder/CEO of Lucy Therapeutics, shares her amazing story of driving disruptive innovation in the biotech industry. She describes her scientific "curiosity" that led to the formulation of her disruptive idea, and the gutsy "courage" that drove her to found Lucy Therapeutics against all odds, overcoming the industry's significant resistance.
Visit LinkDecember 14, 2022
BioCentury
Lucy: mitochondrial solutions to CNS diseases. Lucy Therapeutics views mitochondrial dysfunction as a common and core driver of many CNS diseases, and aims to build a pipeline of programs against “rate-limiting” targets that gate the progression of that dysfunction.
Visit LinkDecember 7, 2022
Longevity Technology
Do mitochondria hold the key to a Parkinson’s breakthrough? Lucy Therapeutics founder on mitochondria, Parkinson’s and the importance of hypothesis-driven research and development.
Visit LinkNovember 19, 2022
Cultivating Greatness
Podcast: A creative conversation with Amy Ripka, Founder/CEO of Lucy Therapeutics and professional violinist, about how she leverages the principles of performing music to her own leadership practice.
Visit LinkSeptember 12, 2022
Clinical Leader
Beyond Nuclear Genetics: Let's Think Differently About CNS Disease Targets.
Visit LinkFebruary 11, 2021
ACS Boss Talk
Amy Ripka has over 30 issued patents and has been involved in multiple INDs in different therapeutic areas. She has deep connections in the medicinal chemistry community with long-time service to the ACS MEDI Executive Committee and was the elected Chair of the 2012 Medicinal Chemistry Gordon Research Conference.
Visit LinkSeptember 16, 2020
University of Wisconsin-Madison News
A Rich History of Research and Mentorship
Visit LinkMarch 8, 2020
Chemical & Engineering News
Amy Ripka on being a CEO: ‘Nobody ever got anywhere by listening to No’
Visit Link